Peter Bannasch
- Hepatology top 1%
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 18
- Carcinogens and Genotoxicity Assessment 17
- Biochemistry top 1%
- Amino Acid Enzymes and Metabolism 18
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 16
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 19
-
- Liver Disease Diagnosis and Treatment 28
-
- Metabolism and Genetic Disorders 22
-
- Glycogen Storage Diseases and Myoclonus 22
Peter Bannasch
228 papers receiving 5.4k citations
Peers
Comparison fields: 5 of 132
- Hepatology 874
- Cancer Research 1.6k
- Biochemistry 372
- Pharmacology 437
- Oncology 1.1k
Countries citing papers authored by Peter Bannasch
This map shows the geographic impact of Peter Bannasch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bannasch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bannasch more than expected).
Fields of papers citing papers by Peter Bannasch
This network shows the impact of papers produced by Peter Bannasch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bannasch. The network helps show where Peter Bannasch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Bannasch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 11 | |
| 2 | 2000 | 7 | |
| 3 | 2000 | 26 | |
| 4 | 1999 | 5 | |
| 5 | 1998 | 23 | |
| 6 | 1998 | 179 | |
| 7 | 1998 | 6 | |
| 8 | Pathology of neoplasia and preneoplasia in rodents : EULEP color atlas | 1994 | 4 |
| 9 | 1994 | 9 | |
| 10 | Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis. | 1993 | 41 |
| 11 | 1991 | 9 | |
| 12 | 1990 | 26 | |
| 13 | Liver cell carcinoma | 1989 | 36 |
| 14 | 1989 | 22 | |
| 15 | 1988 | 11 | |
| 16 | 1988 | 9 | |
| 17 | Cancer risks : strategies for elimination | 1987 | 8 |
| 18 | Bioassays for carcinogenicity in animals. Assays for initiating and promoting activities. | 1986 | 3 |
| 19 | Mitochondrial anomalies in renal oncocytes induced in rat by N-nitrosomorpholine. | 1981 | 26 |
| 20 | [Morphogenesis and fine structure of basophilic and oncocytic renal tumors in nitrosamine-intoxicated rats (author's transl)]. | 1971 | 7 |
About Peter Bannasch
Peter Bannasch is a scholar working on Hepatology, Clinical Biochemistry, Cancer Research, Biochemistry and Pharmacology, having authored 230 papers that have together received 5.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (28 papers), Metabolism and Genetic Disorders (22 papers), Glycogen Storage Diseases and Myoclonus (22 papers), Drug Transport and Resistance Mechanisms (19 papers), Amino Acid Enzymes and Metabolism (18 papers), Cancer, Hypoxia, and Metabolism (18 papers), Carcinogens and Genotoxicity Assessment (17 papers) and Pharmacogenetics and Drug Metabolism (16 papers). The work is most often cited by research in Hepatology (874 citations), Cancer Research (1.6k citations), Biochemistry (372 citations), Pharmacology (437 citations) and Oncology (1.1k citations). Peter Bannasch has collaborated with scholars based in Germany, Japan and United States. Frequent co-authors include Doris Mayer, Heide Zerban, Hans Jörg Hacker, Fritz Klimek, Malcolm A Moore, Qin Su, Edgar Weber, Gerd Otto, Rainer Krech and Harald Enzmann. Their work appears in journals such as Carcinogenesis, Journal of Cancer Research and Clinical Oncology, Toxicologic Pathology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.